Our Programs
The Academy
The Academy is a life sciences accelerator program that develops research-led founders while advancing their ventures toward investment readiness. Delivered by the Sydney Biomedical Accelerator in partnership with Proto Axiom, it is designed for researchers with promising, potentially investable assets who are motivated to lead their own commercial pathway. Selected researchers, known as Academy Fellows, are embedded within Proto Axiom’s venture environment for hands-on founder development, while advancing their own venture through an investor-guided de-risking program.
Applications close on 22 January 2027.
Biodesign Sydney
The Sydney Biomedical Accelerator is the principal partner for the 2026 Biodesign Sydney Program—an intensive, hands on experience for aspiring biomedical innovators. The program allows multidisciplinary teams to undertake a period of immersion in a hospital setting to identify unmet clinical needs and develop innovative solutions. Participants also receive training in medical device development processes, patent writing, regulation, IP, and business and funding strategies. Applications for the 2026 program closed in July.
Venture Studio
The Sydney Biomedical Accelerator Venture Studio is a hands-on commercialisation initiative designed to transform our most promising biomedical research into investable ventures. Selected projects receive a dedicated venture lead with deep biotech commercialisation expertise, a customised development plan and access to business development, clinical, and commercialisation insights from across the Sydney Biomedical Accelerator ecosystem. Two projects were selected for the Venture Studio in 2026.